Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | PRKD3 | O94806 | 2/20 | 0.55 |
| ▸ | PRKCG | P05129 | 2/20 | 0.55 |
| ▸ | PRKCB | P05771 | 2/20 | 0.55 |
| ▸ | PRKCA | P17252 | 2/20 | 0.55 |
| ▸ | PRKCH | P24723 | 2/20 | 0.55 |
| ▸ | PRKCI | P41743 | 2/20 | 0.55 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.55 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.55 |
| ▸ | PRKCZ | Q05513 | 2/20 | 0.55 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.55 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 13/20 | 0.53 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10975586 | 0.98 | ALDH1A1 (0.72) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL16942553 | 0.98 | ALDH1A1 (0.72) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL7136174 | 0.98 | ALDH1A1 (0.72) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL11078988 | 0.98 | ALDH1A1 (0.65) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL8777442 | 0.98 | ALDH1A1 (0.72) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL11076995 | 0.96 | ALDH1A1 (0.69) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL8777394 | 0.96 | ALDH1A1 (0.69) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL11075632 | 0.90 | ALDH1A1 (0.67) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL9790759 | 0.89 | ALDH1A1 (0.59) | ALDH1A1PRKD3PRKCGPRKCBPRKCA | |
| SCHEMBL22960121 | 0.88 | ALDH1A1 (0.63) | ALDH1A1PRKD3PRKCGPRKCBPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0574510-B1 | 2,4-DIARYL-1,3-DITHIOLANES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS | CT FOR INNOVATIVE TECHNOLOGY (US) | 2001-09-05 | — | — | EP | disclosed |
| CN-1053665-C | 2,4-diaryl-1,3-dithiolanes, 2,4-diaryl-1,3-dioxolanes, 2,4-diaryl-1, 3-oxathiolanes, and 2,5-diaryl-1, 3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or.......... | INNOVATIVE TECH CENTER (US) | 2000-06-21 | — | — | CN | disclosed |
| CN-1053665-C | 2,4-diaryl-1,3-dithiolanes, 2,4-diaryl-1,3-dioxolanes, 2,4-diaryl-1, 3-oxathiolanes, and 2,5-diaryl-1, 3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or.......... | INNOVATIVE TECH CENTER (US) | 2000-06-21 | — | — | CN | disclosed |
| US-5639782-A | ANTIINFLAMMATORY AGENT; ANTIALLERGENS | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1997-06-17 | — | — | US | disclosed |
| US-5530141-A | REDUCES THE CHEMOTAXIS AND RESPIRATORY BURST LEADING TO THE FORMATION OF DAMAGING OXYGEN RADICAL DURING INFLAMMATORY AND IMMUNE RESPONSE | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1996-06-25 | — | — | US | disclosed |
| US-5530141-A | REDUCES THE CHEMOTAXIS AND RESPIRATORY BURST LEADING TO THE FORMATION OF DAMAGING OXYGEN RADICAL DURING INFLAMMATORY AND IMMUNE RESPONSE | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1996-06-25 | — | — | US | disclosed |
| US-5530141-A | REDUCES THE CHEMOTAXIS AND RESPIRATORY BURST LEADING TO THE FORMATION OF DAMAGING OXYGEN RADICAL DURING INFLAMMATORY AND IMMUNE RESPONSE | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1996-06-25 | — | — | US | disclosed |
| EP-0574510-A4 | NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS | INNOVATIVE TECH CENTER (US) | 1994-07-06 | — | — | EP | disclosed |
| WO-1994006790-A1 | 2,4-DIARYL-1,3-DITHIOLANES; 2,4-DIARYL-1,3-DIOXOLANES; 2,4-DIARYL-1,3-OXATHIOLANES; AND 2,5-DIARYL-1,3-OXATHIOLANES AS PAF RECEPTOR ANTGONISTS AND INHIBITORS OF 5-LIPOXYGENASE | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1994-03-31 | — | — | WO | disclosed |
| WO-1994006790-A1 | 2,4-DIARYL-1,3-DITHIOLANES; 2,4-DIARYL-1,3-DIOXOLANES; 2,4-DIARYL-1,3-OXATHIOLANES; AND 2,5-DIARYL-1,3-OXATHIOLANES AS PAF RECEPTOR ANTGONISTS AND INHIBITORS OF 5-LIPOXYGENASE | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1994-03-31 | — | — | WO | disclosed |
| WO-1994004537-A2 | DUAL FUNCTIONAL ANTI-INFLAMMATORY AND IMMUNOSUPPRESSIVE AGENTS | CYTOMED, INC. (US) | 1994-03-03 | — | — | WO | disclosed |
| EP-0574510-A1 | NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1993-12-22 | — | — | EP | disclosed |
| WO-1992015294-A1 | NEOLIGNAN DERIVATIVES AS PLATELET ACTIVATING FACTOR RECEPTOR ANTAGONISTS AND 5-LIPOXYGENASE INHIBITORS | CENTER FOR INNOVATIVE TECHNOLOGY (US) | 1992-09-17 | — | — | WO | disclosed |